-
RBC Upgrades Coca-Cola's Stock, Says 'Things Have Changed'
Monday, March 8, 2021 - 2:43pm | 302Read More...The case for turning bullish on Coca-Cola Co (NYSE: KO) is simple: "things have changed," according to RBC. The Coca-Cola Analyst: Nik Modi upgraded Coca-Cola's stock from Sector Perform to Outperform with a price target lifted from $55 to $60. The Coca-Cola Thesis: RBC...
-
Accelerated Vaccine Timeline Will 'Inspire Confidence' In Travel Says Marriott CEO
Wednesday, March 3, 2021 - 2:10pm | 421Read More...The White House expects all adults who want a vaccine against the coronavirus will be able to get one by the end of May and this will "inspire confidence" in travel, Marriott International Inc (NASDAQ: MAR) CEO Tony Capuano said on Fox Business. What Happened: U.S. President Joe...
-
One Medical Under Investigation By House Subcommittee, Allegedly Let Subscribers Cut COVID-19 Vaccine Line
Tuesday, March 2, 2021 - 5:11pm | 370Read More...One Medical, a subscription-based concierge health care provider, is now under investigation by a Congressional committee, accused of administering COVID-19 vaccines to family, friends, executives and wealthy clients, according to CNBC. What Happened: One Medical is owned by ...
-
NanoViricides Jumps On 'Strong Pan-Coronavirus Effectiveness' From 2 COVID-19 Candidates In Lab Studies
Tuesday, March 2, 2021 - 11:37am | 454Read More...Shares of nano-cap biopharma NanoViricides, Inc. (NASDQ: NNVC) were trading solidly higher Tuesday following a positive data readout. What Happened: Two NanoViricides COVID-19 clinical drug candidates — NV-CoV-2 and NV-CoV-2-R — have shown "strong pan-coronavirus...
-
Airbnb Beats The Street's Revenue Estimate In First Earnings Report
Thursday, February 25, 2021 - 5:57pm | 290Read More...The home rental company Airbnb reported its first earnings as a public company Thursday in the wake of a pandemic that has upended the travel industry. What Happened: Airbnb Inc (NASDAQ: ABNB), which went public in 2020, reported fourth-quarter and full fiscal 2020 earnings. The company...
-
Pfizer-BioNTech Vaccine 94% Effective In Real World: Study
Thursday, February 25, 2021 - 8:03am | 281Read More...A real-world study of the coronavirus vaccine developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) showed the drug to be 94 percent effective at preventing COVID-19. What Happened: The large-scale study conducted in Israel found the two-dose vaccine reduced symptomatic cases by...
-
Johnson & Johnson's Single-Dose Coronavirus Shot Gets Favorable FDA Review Ahead Of Adcom Meeting
Wednesday, February 24, 2021 - 11:14am | 516Read More...Johnson & Johnson (NYSE: JNJ) shares were advancing Wednesday following the release of the FDA briefing document meant for the Friday Adcom meeting to discuss the company's coronavirus vaccine candidate. What Happened: Johnson & Johnson's single-shot vaccine —...
-
Ex-FDA Commissioner Gottlieb On COVID-19: 'Things Will Be Normal In The Spring And Summer'
Monday, February 22, 2021 - 1:17pm | 401Read More...The United States has so far rolled out more than 63 million COVID-19 vaccine doses with an average of 1.3 million doses administered per dayy. Continued momentum in the vaccination effort implies the U.S. could return to a form of normalcy within a few months, according to former FDA...
-
Novavax Achieves Target Enrollment In Pivotal Phase 3 Coronavirus Vaccine Study In US, Mexico
Monday, February 22, 2021 - 8:47am | 352Read More...Novavax, Inc. (NASDAQ: NVAX) has taken another step toward obtaining emergency use authorization for NVX-CoV2373, its recombinant protein-based vaccine candidate against the novel coronavirus. What Happened: Maryland-based Novavax said it has completed enrollment of the PREVENT-19, pivotal Phase 3...
-
Immunome Shares Spike 150% Higher On Coronavirus Antibody Discovery
Thursday, February 18, 2021 - 9:27am | 373Read More...Shares of micro-cap biopharma Immunome Inc (NASDAQ: IMNM) are indicated to open Thursday's session sharply higher. What Happened: Immunome, which focuses on developing antibody therapies, said its discovery engine has isolated potent antibodies capable of neutralizing several SARS-CoV-2...
-
Vir Biotech Expands Vaccine Collaboration With GlaxoSmithKline: What You Need to Know
Wednesday, February 17, 2021 - 11:06am | 499Read More...Vir Biotechnology Inc (NASDAQ: VIR) shares were advancing Wednesday after the company announced an expansion of its coronavirus vaccine collaboration with GlaxoSmithKline plc (NYSE: GSK). What Happened: Vir and GlaxoSmithKline signed an agreement to expand an existing...
-
Inovio Shares Rally As Oppenheimer Says Coronavirus Vaccine Developer Approaching Finish Line
Friday, February 12, 2021 - 3:46pm | 617Read More...Shares of coronavirus vaccine developer Inovio Pharmaceuticals Inc (NASDAQ: INO) were surging Friday after a vote of confidence from the Street. Bullish Analyst, Fund Stake Prop Up Stock: Oppenheimer analyst Hartaj Singh initiated coverage of Inovio shares with an Outperform rating and...
-
COVID-19 Vaccine Updates: US Strikes 100M-Dose Supply Deals With Moderna, Pfizer, EU Starts Rolling Review Of CureVac Vaccine
Friday, February 12, 2021 - 12:27pm | 555Read More...Coronavirus vaccine news supply deals and a regulatory filing are in the headlines in Friday's trading session. US Secures More Vaccine Doses: Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE), the two companies that have received emergency use authorization for...
-
DoorDash Partners With Cellex, Will Offer Discounted COVID-19 Tests To Small Restaurants
Thursday, February 11, 2021 - 6:31pm | 339Read More...Third party restaurant and food delivery platform DoorDash Inc (NYSE: DASH) is working with Cellex, a point-of-care testing company, to offer 1,150 COVID-19 testing kits to independent merchants on the platform with three or fewer locations. What Happened: DoorDash's motivation to partner...
-
Novavax Shares Pass The $300 Mark: Is The Rally Sustainable?
Monday, February 8, 2021 - 4:39pm | 478Read More...Novavax, Inc.'s (NASDAQ: NVAX) recent hot streak is continuing, as the stock moved past $300 Monday. What Happened: After ending 2020 on a strong note, shares of Gaithersburg, Maryland-based Novavax have been going from strength to strength in the new year. The stock...
















